Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [123I]IBZM SPECT study
- 25 August 2001
- journal article
- clinical trial
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 107 (2) , 87-97
- https://doi.org/10.1016/s0925-4927(01)00085-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [ 123 I]epidepride single photon emission tomography (SPET) studyPsychopharmacology, 2000
- In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugsThe British Journal of Psychiatry, 1999
- 5-HT2 and D2 Receptor Occupancy of Olanzapine in Schizophrenia: A PET InvestigationAmerican Journal of Psychiatry, 1998
- Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levelsPsychiatry Research: Neuroimaging, 1997
- Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epideprideSynapse, 1996
- [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neurolepticsAmerican Journal of Psychiatry, 1996
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987